Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$0.1.

  • Abeona Therapeutics' EPS (Basic) rose 8412.7% to -$0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.59, marking a year-over-year increase of 17098.21%. This contributed to the annual value of -$1.55 for FY2024, which is 3878.42% up from last year.
  • Abeona Therapeutics' EPS (Basic) amounted to -$0.1 in Q3 2025, which was up 8412.7% from $2.07 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year EPS (Basic) high stood at $2.07 for Q2 2025, and its period low was -$11.86 during Q4 2021.
  • Its 5-year average for EPS (Basic) is -$1.31, with a median of -$0.63 in 2024.
  • In the last 5 years, Abeona Therapeutics' EPS (Basic) crashed by 684067.62% in 2021 and then skyrocketed by 98947.37% in 2025.
  • Over the past 5 years, Abeona Therapeutics' EPS (Basic) (Quarter) stood at -$11.86 in 2021, then soared by 92.38% to -$0.9 in 2022, then increased by 14.03% to -$0.78 in 2023, then skyrocketed by 70.95% to -$0.23 in 2024, then surged by 55.67% to -$0.1 in 2025.
  • Its EPS (Basic) was -$0.1 in Q3 2025, compared to $2.07 in Q2 2025 and -$0.24 in Q1 2025.